CompaniesByCap
AIM
AIM ImmunoTech Inc. (AIM)
NYSE · Healthcare

AIM ImmunoTech Inc. Income Statement 2009–2025

Income StatementBalance SheetCash Flow
Dec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012Dec 2011Dec 2010Dec 2009
Revenues
Revenue88,000170,000202,000141,000135,000163,000140,000367,000437,00092,000133,000197,000150,000213,000161,000135,000111,000
Gross Profit-1.1M-1.1M-1.8M-882,000-1.2M-473,000
Profitability
Operating Income-11.7M-19.8M-31.9M-19.9M-18.8M-15.2M-12.4M-11.5M-11.4M-13.8M-16.6M-19.1M-17.2M-20.3M-14.3M-16.4M-13.3M
EBITDA
Net Income-14.0M-17.3M-29.0M-19.4M-19.1M-14.4M-9.4M-9.8M-8.3M-7.5M-15.2M-17.4M-16.2M
Per Share Data
EPS (diluted)
Shares Outstanding (dil.)2M1M49M48M48M42M10M1M33M24M21M204M169M166M136M135M

AIM ImmunoTech Inc. Income Statement — FAQ

AIM ImmunoTech Inc. (AIM) income statement over the last 17 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see AIM's income statement history?

The chart and table above show AIM ImmunoTech Inc.'s income statement by year and by quarter, including the growth rate.